185 related articles for article (PubMed ID: 37948046)
1. Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery.
Zimmer L
Expert Opin Drug Discov; 2024 Feb; 19(2):161-172. PubMed ID: 37948046
[TBL] [Abstract][Full Text] [Related]
2. Positron Emission Tomography for the Discovery of New Drugs in Psychiatry.
Zimmer L
ACS Chem Neurosci; 2023 Feb; 14(4):524-526. PubMed ID: 36726331
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomographic imaging in drug discovery.
Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
[TBL] [Abstract][Full Text] [Related]
4. Positron emitting tracers in pre-clinical drug development.
Fernandes E; Barbosa Z; Clemente G; Alves F; Abrunhosa AJ
Curr Radiopharm; 2012 Apr; 5(2):90-8. PubMed ID: 22280107
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography molecular imaging for drug development.
Matthews PM; Rabiner EA; Passchier J; Gunn RN
Br J Clin Pharmacol; 2012 Feb; 73(2):175-86. PubMed ID: 21838787
[TBL] [Abstract][Full Text] [Related]
6. The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology.
Malizia AL
J Psychopharmacol; 2006 Jul; 20(4 Suppl):100-7. PubMed ID: 16785278
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive imaging in experimental medicine for drug development.
Matthews PM; Rabiner I; Gunn R
Curr Opin Pharmacol; 2011 Oct; 11(5):501-7. PubMed ID: 21570913
[TBL] [Abstract][Full Text] [Related]
8. PET as a Translational Tool in Drug Development for Neuroscience Compounds.
Varrone A; Bundgaard C; Bang-Andersen B
Clin Pharmacol Ther; 2022 Apr; 111(4):774-785. PubMed ID: 35201613
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography in CNS drug discovery and drug monitoring.
Piel M; Vernaleken I; Rösch F
J Med Chem; 2014 Nov; 57(22):9232-58. PubMed ID: 25144329
[TBL] [Abstract][Full Text] [Related]
10. The application of positron emission tomography (PET) imaging in CNS drug development.
Suridjan I; Comley RA; Rabiner EA
Brain Imaging Behav; 2019 Apr; 13(2):354-365. PubMed ID: 30259405
[TBL] [Abstract][Full Text] [Related]
11. Modeling of PET data in CNS drug discovery and development.
Varnäs K; Varrone A; Farde L
J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):267-79. PubMed ID: 23660778
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development.
Bergström M; Grahnén A; Långström B
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):357-66. PubMed ID: 12937873
[TBL] [Abstract][Full Text] [Related]
13. Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
Langer O
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S143-56. PubMed ID: 27385172
[TBL] [Abstract][Full Text] [Related]
14. Psychopharmacology--in vivo neurochemistry and pharmacology.
Grasby P; Malizia A; Bench C
Br Med Bull; 1996 Jul; 52(3):513-26. PubMed ID: 8949254
[TBL] [Abstract][Full Text] [Related]
15. Approaches using molecular imaging technology -- use of PET in clinical microdose studies.
Wagner CC; Langer O
Adv Drug Deliv Rev; 2011 Jun; 63(7):539-46. PubMed ID: 20887762
[TBL] [Abstract][Full Text] [Related]
16. Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide.
Burt T; John CS; Ruckle JL; Vuong LT
Expert Opin Drug Deliv; 2017 May; 14(5):657-672. PubMed ID: 27564533
[TBL] [Abstract][Full Text] [Related]
17. [Molecular imaging-based early-phase and exploratory clinical research].
Watanabe Y
Yakugaku Zasshi; 2013; 133(2):187-95. PubMed ID: 23370512
[TBL] [Abstract][Full Text] [Related]
18. Translational PET imaging research.
Hargreaves RJ; Rabiner EA
Neurobiol Dis; 2014 Jan; 61():32-8. PubMed ID: 24055214
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of a new series of radiolabeled ligands for 5-HT7 receptor PET neuroimaging.
Colomb J; Becker G; Forcellini E; Meyer S; Buisson L; Zimmer L; Billard T
Nucl Med Biol; 2014 Apr; 41(4):330-7. PubMed ID: 24607435
[TBL] [Abstract][Full Text] [Related]
20. Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.
Matthews PM; Datta G
Expert Opin Drug Discov; 2015 May; 10(5):557-70. PubMed ID: 25843125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
